Skip to main navigation Skip to search Skip to main content

A multicenter, randomized, open-label, blinded endpoint evaluation, phase 3 study comparing the effect of abelacimab relative to apixaban on venous thromboembolism (VTE) recurrence and bleeding in patients with cancer associated VTE (ASTER)

  • Chunilal, Sanjeev (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date6/09/22 → 5/09/27

Keywords

  • multicentre trial
  • Randomised clinical trial
  • treatment safety
  • treatment efficacy
  • thromboembolism

Clinical Trial Phase

  • Phase III (a & b)